Association between cardiometabolic comorbidities and parkinson’s disease in a mexican population

2Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Background: The prevalence of Parkinson’s disease (PD) increases as the population ages. Studies have shown that some cardiometabolic comorbidities could be associated with risk or protection against developing PD. A retrospective case-control study was carried out to analyze the relationship between PD and cardiometabolic comorbidities. Material and methods: Subjects with PD and controls without PD were consecutively recruited. Data on type 2 diabetes mellitus, systemic arterial hypertension (SAH), dyslipidemia and body mass index were collected. Logistic regression analyses were carried out. Results: A total of 781 subjects with PD (56.5% male) and 1,000 controls (44.4% males) were included. After adjusting for age and gender, SAH was found as an independent risk factor (OR 1.32, CI 95% 1.05-1.67, p=0.02), and obesity a protective factor (OR 0.72, CI 95% 0.56-0.93, p=0.01). Conclusion: Subjects with SAH had an higher risk of having PD. while obese subjects had a lower risk of having PD. The relationship between cardiometabolic disease, its treatment, and PD etiopathogenesis ap-pears to be extremely complex given the amount of contradictory data.

Cite

CITATION STYLE

APA

Cervantes-Arriaga, A., Esquivel-Zapata, Ó., Escobar-Valdivia, E., García-Romero, D., Alcocer-Salas, Á., & Rodríguez-Violante, M. (2021). Association between cardiometabolic comorbidities and parkinson’s disease in a mexican population. Gaceta Medica de Mexico, 157(6), 645–650. https://doi.org/10.24875/GMM.21000294

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free